Premium
P4‐308: Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer's disease: A phase ii multicenter randomized controlled trial
Author(s) -
Xiao Shifu,
Wang Tao,
Li Xia,
Zhao Zhongxin,
Liu Xueyuan,
Wang Xiaoping,
Xie Hengge,
Sun Li,
Jiang Qinpu,
Luo Benyan,
Shang Lan,
Chen Weixian,
Bai Yan,
Tang Muni,
He Maolin,
Liu Kaixiang,
Ma Qilin,
Song Zhi,
Qin Yingyyi,
Ma Xiuqiang,
He Jia
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.08.138
Subject(s) - placebo , medicine , randomized controlled trial , clinical global impression , clinical trial , alzheimer's disease , adverse effect , gastroenterology , disease , pathology , alternative medicine